Employment, treatment and lung function outcomes at 1-year following diagnosis of occupational hypersensitivity pneumonitis

N. Kongsupon (Birmingham (West Midlands), United Kingdom), G. Burge (Birmingham (West Midlands), United Kingdom), A. Robertson (Birmingham (West Midlands), United Kingdom), V. Moore (Birmingham (West Midlands), United Kingdom), S. Sadhra (Birmingham (West Midlands), United Kingdom), S. Burge (Birmingham (West Midlands), United Kingdom), G. Walters (Birmingham (West Midlands), United Kingdom)

Source: Virtual Congress 2020 – Occupational exposure as a cause of respiratory disease
Session: Occupational exposure as a cause of respiratory disease
Session type: E-poster session
Number: 661
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Kongsupon (Birmingham (West Midlands), United Kingdom), G. Burge (Birmingham (West Midlands), United Kingdom), A. Robertson (Birmingham (West Midlands), United Kingdom), V. Moore (Birmingham (West Midlands), United Kingdom), S. Sadhra (Birmingham (West Midlands), United Kingdom), S. Burge (Birmingham (West Midlands), United Kingdom), G. Walters (Birmingham (West Midlands), United Kingdom). Employment, treatment and lung function outcomes at 1-year following diagnosis of occupational hypersensitivity pneumonitis. 661

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary function trends predict mortality in patients with hypersensitivity pneumonitis
Source: International Congress 2018 – Granulomatous disorders: epidemiology, genotype and phenotype
Year: 2018



Occupational asthma: outcome according to cessation or reduction of exposure
Source: Annual Congress 2006 - Asthma at the workplace – the prognosis and the costs
Year: 2006


Clinical characteristics and corticosteroid treatment of acute eosinophilic pneumonia
Source: Eur Respir J 2013; 41: 402-409
Year: 2013



Profiling of hypersensitivity pneumonitis diagnosed at a UK specialist service for ILD and occupational lung diseases
Source: International Congress 2018 – Occupational and environmental lung diseases: asthma and the airways
Year: 2018



Incidence, comorbidity and survival rate of hypersensitivity pneumonitis: a national population-based study
Source: ERJ Open Res, 5 (4) 00259-2018; 10.1183/23120541.00259-2018
Year: 2019



Early exposure or sensitization to pets and subsequent asthma: a 20-year prospective post-bronchiolitis follow-up
Source: Annual Congress 2006 - Bronchiolitis in infancy, treatment and outcome
Year: 2006


What is the optimal management option for occupational asthma?
Source: Eur Respir Rev 2012; 21: 97-104
Year: 2012



Predicting treatment outcomes following an exacerbation of airways disease
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019


Diagnosis, course and management of hypersensitivity pneumonitis
Source: Eur Respir Rev, 31 (163) 210169; 10.1183/16000617.0169-2021
Year: 2022



Mortality, morbidity and occupational exposure to airway irritating agents among men with an allergy diagnosis in adolescence
Source: Annual Congress 2007 - Occupation and obstruction
Year: 2007



The psychological status of COPD patients: the impact of the long-term complex treatment and pulmonary rehabilitation
Source: Eur Respir J 2003; 22: Suppl. 45, 53s
Year: 2003

Mortality risk prediction with ILD-GAP index in a portuguese chronic hypersensitivity pneumonitis cohort
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021


Incidence, comorbidity and survival rate of hypersensitivity pneumonitis: A population-based study
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Year: 2018




Occupational asthma: getting the diagnosis right in primary care
Source: Annual Congress 2007 - Primary care: managing special cases in lung disease
Year: 2007


Inflammatory biomarkers in the evaluation of two-year  outcomes  of omalizumab treatment in severe allergic asthma.
Source: International Congress 2018 – Biomarkers for evaluating asthma
Year: 2018

Long-term follow-up of sensitization and lung function in bakers with flour-induced asthma after cessation of exposure
Source: Eur Respir J 2001; 18: Suppl. 33, 277s
Year: 2001

The predictive value of symptoms for asthma diagnosis and inhaled steroid treatment response
Source: International Congress 2016 – Asthma management in primary care
Year: 2016


The effectiveness of pulmonary rehabilitation including occupational therapy in patients with chronic pulmonary emphysema
Source: Eur Respir J 2002; 20: Suppl. 38, 376s
Year: 2002

Evaluation of severity, inflammatory response and adherence to treatment guidelines impact on community-acquired pneumonia outcomes
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008